Division 1 | Cognitive Neuropsychiatry & Clinical Neuroscience
Aim and mission
Researchers in this division investigate both the effects of biological, neuropsychological and psychosocial factors, and the effects of ageing on cognition, and on the progression of neurological diseases itself. Research of Division 1 is related to neuropsychiatric and neurological disorders studied in clinical cohorts (e.g. patients with Alzheimer’s disease, stroke and brain injury) and in cohorts of healthy ageing subjects, focusing on cognitive functioning and its consequences. Research and care are highly integrated in centers, such as the Alzheimer Centrum Limburg, the Limburg Brain Injury Center, and the Center for Movement Disorders.
With respect to the core topics, the focus is upon:
- Neurodegeneration of the Central Nervous System: Alzheimer’s disease and its prodromal phases, other dementias
- Vascular Cognitive Impairment and Stroke
- Parkinson’s disease
- Peripheral nervous system disease
- Acquired brain damage
- Multiple Sclerosis
- Epilepsy
Strategy
The Division Cognitive Neuropsychiatry & Clinical Neuroscience (CNP&CNS) performs fundamental and applied patient-related multi-disciplinary research on cognitive disorders and other neurological and otorinolaryngological disorders and their consequences, to generate new insights into the mechanisms of these conditions. The ultimate goal is to improve diagnosis, prognosis and treatment, to enhance quality of life of people with cognitive and other neurological disorders.
Division Leader
Dr. Jaap Jansen
Division Deputies
Prof. Seb Köhler
Dr. Janneke Hoeijmakers
Secretary
Danielle Moens